Lv4
460 积分 2024-01-12 加入
Engineering Oxaliplatin(IV) Prodrugs with Monohaloacetates for Redox-Responsive and Multimodal Anticancer Activity
1天前
待确认
Cyclic peptide-decorated PtIV-DCA prodrug triggers ferroptosis in glioblastoma via the disruption of energy metabolism
6天前
已关闭
MN42–81: A novel PD-L1-targeted immunomodulatory cisplatin prodrug for highly efficient synergistic chemo-immunotherapy of cancer
9天前
已完结
Design, synthesis, and anti-necroptotic activity of novel Phenylbenzothiazole receptor-interacting protein kinase 1 (RIPK1) inhibitors
21天前
已完结
Organelle-Targeted Photodynamic Platforms: From ICD Activation to Tumor Ablation
21天前
已完结
Efektivitas Kombinasi Agen Pendeplesi Glutathione (GSH) dan Inhibitor Glutathione S-Transferase (GST) pada Resistensi Cisplatin terhadap Sel Kanker: Systematic Literature Review
30天前
已关闭
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
30天前
已完结
What do we know about the reduction of Pt(IV) pro-drugs?
1个月前
已完结
Novel anticancer paeonol derivatives possessing a nitric oxide donor moiety as TrxR inhibitors: design, synthesis, biological evaluation
1个月前
已关闭
Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
1个月前
已完结
Bistatic Radar
3个月前
已采纳
Pediatric Nutrition
3个月前
已驳回
皖公网安备34019202002308
